Counterpoint:第三季全球手機出貨量3.66億台 小米(01810.HK)市佔第三
調查機構Counterpoint發表的報告指,今年第三季全球手機市場呈復甦跡象,出貨量按年跌4%至3.66億台,但按季則大增32%,復甦主要是受惠美國、印度、拉丁美洲市場隔離措施有所放寬,意味在疫情下智能手機市場供求兩方面均有彈性。
該行的分析指出,主要市場隔離措施放寬為出入口帶來了空間,同時亦對供應鏈有利,受惠中國及越南生產開始回後至正常水平,供應方面的問題得以解決,而印度的生產亦已回到疫情前的八成水平,歐美的返校需求也對市場復甦有利。
按品牌劃分,三星出貨量按年升2%至7,980萬台,市佔率22%排全球首位,而華為出貨量則大跌24%至5,090萬台,位列第二,值得留意的是小米(01810.HK)出貨量首次超蘋果(AAPL.US)排第三位,出貨量按年大增46%至4,620萬台,創新高。(el/u) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.